Insulin resistance, chronic inflammatory state and the link with systemic lupus erythematosus-related coronary disease

被引:45
作者
Escarcega, Ricardo O.
Garcia-Carraseo, Mario
Fuentes-Alexandro, Salvador
Jara, Luis J.
Rojas-Rodriguez, Jorge
Escobar-Linares, Luis E.
Cervera, Ricard
机构
[1] Hosp Clin Barcelona, Serv Malalties Autoimmunes, Inst Clin Med Dermatol, E-08036 Barcelona, Spain
[2] Inst Mexicano Seguro Social, Syst Autoimmune Dis Res Unit, HGR 36, Puebla, Mexico
[3] Univ Autonoma Puebla, Dept Rheumatol & Immunol, Puebla 72570, Mexico
[4] Ctr Med Raza, Clin Res Unit, Hosp Especialidades, Mexico City, DF, Mexico
[5] Univ Nacl Autonoma Mexico, Mexico City 04510, DF, Mexico
[6] Hosp Guadalupe Puebla, Dept Endocrinol, Puebla, Mexico
关键词
atherosclerosis; inflammation; insulin resistance; SLE;
D O I
10.1016/j.autrev.2006.07.001
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The association of SLE with atherosclerosis suggests a common pathogenic mechanism. SLE and atherosclerosis are immune complex-mediated diseases. The integration of metabolism and immunity, which under normal conditions is beneficial for the maintenance of good health, can become deteriorative under conditions of metabolic challenge, as exemplified by the immunosuppression characteristic of malnourished or starving individuals. It is now apparent that obesity is associated with a state of chronic inflammation, particularly in white adipose tissue. However, in the absence of obesity, infusion of animals with inflammatory cytokines or lipids can cause insulin resistance. It is possible that the stresses of obesity are similar enough to the stresses of an infection and the body reacts to obesity as it would to an infection. Atherosclerosis can be considered to have a significant chronic inflammatory component. Inflammation also contributes to the typical dyslipidemia associated with SLE that is characterized by elevations of VLDL, LDL and triglycerides as well as reduced HDL. The link between insulin resistance and SLE can be explained by the chronic inflammatory state, and the consequent dyslipoproteinemia. (c) 2006 Elsevier B.V All rights reserved.
引用
收藏
页码:48 / 53
页数:6
相关论文
共 40 条
[1]   Insulin inhibits the pro-inflammatory transcription factor early growth response gene-1 (Egr)-1 expression in mononuclear cells (MNC) and reduces plasma tissue factor (TF) and plasminogen activator inhibitor-1 (PAI-1) concentrations [J].
Aljada, A ;
Ghanim, H ;
Mohanty, P ;
Kapur, N ;
Dandona, P .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (03) :1419-1422
[2]   Association of diabetes and hepatitis C infection: Epidemiologic evidence and pathophysiologic insights [J].
Bahtiyar G. ;
Shin J.J. ;
Aytaman A. ;
Sowers J.R. ;
McFarlane S.I. .
Current Diabetes Reports, 2004, 4 (3) :194-198
[3]   Adipose tissue, inflammation, and cardiovascular disease [J].
Berg, AH ;
Scherer, PE .
CIRCULATION RESEARCH, 2005, 96 (09) :939-949
[4]   Inflammatory cytokines impair endothelium-dependent dilatation in human veins in vivo [J].
Bhagat, K ;
Vallance, P .
CIRCULATION, 1997, 96 (09) :3042-3047
[5]   Atherogenesis and autoimmune disease: the model of lupus [J].
Bruce, IN .
LUPUS, 2005, 14 (09) :687-690
[6]   Risk factors for coronary heart disease in women with systemic lupus erythematosus -: The Toronto Risk Factor Study [J].
Bruce, IN ;
Urowitz, MB ;
Gladman, DD ;
Ibañez, D ;
Steiner, G .
ARTHRITIS AND RHEUMATISM, 2003, 48 (11) :3159-3167
[7]   SLE: challenges and candidates in human disease [J].
Croker, JA ;
Kimberly, RP .
TRENDS IN IMMUNOLOGY, 2005, 26 (11) :580-586
[8]   Cardiac involvement in systemic lupus erythematosus [J].
Doria, A ;
Iaccarino, L ;
Sarzi-Puttini, P ;
Atzeni, F ;
Turriel, M ;
Petri, M .
LUPUS, 2005, 14 (09) :683-686
[9]   Risk factors for subclinical atherosclerosis in a prospective cohort of patients with systemic lupus erythematosus [J].
Doria, A ;
Shoenfeld, Y ;
Wu, R ;
Gambari, PF ;
Puato, M ;
Ghirardello, A ;
Gilburd, B ;
Corbanese, S ;
Patnaik, M ;
Zampieri, S ;
Peter, JB ;
Favaretto, E ;
Iaccarino, L ;
Sherer, Y ;
Todesco, S ;
Pauletto, P .
ANNALS OF THE RHEUMATIC DISEASES, 2003, 62 (11) :1071-1077
[10]   Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and Adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans [J].
Fain, JN ;
Madan, AK ;
Hiler, ML ;
Cheema, P ;
Bahouth, SW .
ENDOCRINOLOGY, 2004, 145 (05) :2273-2282